Product Name:IMIDAZO[1,5-A]PYRIMIDINE

IUPAC Name:imidazo[1,5-a]pyrimidine

CAS:274-67-9
Molecular Formula:C6H5N3
Purity:95%+
Catalog Number:CM415831
Molecular Weight:119.13

Packing Unit Available Stock Price($) Quantity
CM415831-1g 5-6 Weeks ȷƤȦſ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:274-67-9
Molecular Formula:C6H5N3
Melting Point:-
Smiles Code:C1=NC=C2N=CC=CN12
Density:
Catalog Number:CM415831
Molecular Weight:119.13
Boiling Point:
MDL No:MFCD11036148
Storage:

Category Infos

Imidazoles
Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.
Imidazole Manufacturer
As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.
Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.